161 related articles for article (PubMed ID: 1310887)
41. ZYG11A serves as an oncogene in non-small cell lung cancer and influences CCNE1 expression.
Wang X; Sun Q; Chen C; Yin R; Huang X; Wang X; Shi R; Xu L; Ren B
Oncotarget; 2016 Feb; 7(7):8029-42. PubMed ID: 26771237
[TBL] [Abstract][Full Text] [Related]
42. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
43. c-MET/phospho-MET protein expression and MET gene copy number in non-small cell lung carcinomas.
Tsuta K; Kozu Y; Mimae T; Yoshida A; Kohno T; Sekine I; Tamura T; Asamura H; Furuta K; Tsuda H
J Thorac Oncol; 2012 Feb; 7(2):331-9. PubMed ID: 22198430
[TBL] [Abstract][Full Text] [Related]
44. Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers.
Lee SY; Kim MJ; Jin G; Yoo SS; Park JY; Choi JE; Jeon HS; Cho S; Lee EB; Cha SI; Park TI; Kim CH; Jung TH; Park JY
J Thorac Oncol; 2010 Nov; 5(11):1734-40. PubMed ID: 20881644
[TBL] [Abstract][Full Text] [Related]
45. Molecular analysis of p53 and K-ras in lung carcinomas of coal miners.
Sarkar FH; Li Y; Vallyathan V
Int J Mol Med; 2001 Oct; 8(4):453-9. PubMed ID: 11562787
[TBL] [Abstract][Full Text] [Related]
46. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
[TBL] [Abstract][Full Text] [Related]
47. Interaction between transforming growth factor-alpha and c-Ha-ras p21 in progression of human gastric carcinoma.
Yamamoto T; Hattori T; Tahara E
Pathol Res Pract; 1988 Nov; 183(6):663-9. PubMed ID: 3065747
[TBL] [Abstract][Full Text] [Related]
48. Histologic-type specific role of cell cycle regulators in non-small cell lung carcinoma.
Zolota VG; Tzelepi VN; Leotsinidis M; Zili PE; Panagopoulos ND; Dougenis D; Tsamandas AC; Scopa CD
J Surg Res; 2010 Dec; 164(2):256-65. PubMed ID: 19691991
[TBL] [Abstract][Full Text] [Related]
49. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms.
Chang YL; Lee YC; Liao WY; Wu CT
Lung Cancer; 2004 May; 44(2):149-57. PubMed ID: 15084379
[TBL] [Abstract][Full Text] [Related]
50. Lipase member H is a novel secreted protein selectively upregulated in human lung adenocarcinomas and bronchioloalveolar carcinomas.
Seki Y; Yoshida Y; Ishimine H; Shinozaki-Ushiku A; Ito Y; Sumitomo K; Nakajima J; Fukayama M; Michiue T; Asashima M; Kurisaki A
Biochem Biophys Res Commun; 2014 Jan; 443(4):1141-7. PubMed ID: 24380866
[TBL] [Abstract][Full Text] [Related]
51. [Expression of p53, p21 and bcl-2 in prognosis of lung carcinomas].
Nhung NV; Mirejovský T; Mirejovský P; Melínová L
Cesk Patol; 1999 Oct; 35(4):117-21. PubMed ID: 10677910
[TBL] [Abstract][Full Text] [Related]
52. Immunohistochemical evaluation of P21ras and P53 proteins expression in human non-small-cell lung cancers.
Przybojewska B; Rydzynski K; Stepnik M; Jakubiak M; Kozak J; Szymczak W
Neoplasma; 2003; 50(3):198-203. PubMed ID: 12937853
[TBL] [Abstract][Full Text] [Related]
53. HER-2/neu expression in archival non-small cell lung carcinomas using FDA-approved Hercep test.
Scheurle D; Jahanzeb M; Aronsohn RS; Watzek L; Narayanan R
Anticancer Res; 2000; 20(3B):2091-6. PubMed ID: 10928158
[TBL] [Abstract][Full Text] [Related]
54. p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung.
Komiya T; Hosono Y; Hirashima T; Masuda N; Yasumitsu T; Nakagawa K; Kikui M; Ohno A; Fukuoka M; Kawase I
Clin Cancer Res; 1997 Oct; 3(10):1831-5. PubMed ID: 9815570
[TBL] [Abstract][Full Text] [Related]
55. Chemically induced lung and forestomach neoplasias in transgenic mice carry mutant forms of the human c-Ha-ras transgene.
Ogawa K; Imaida K; Masui T; Kawabe M; Hasegawa R; Kato K; Ito N; Shirai T
Carcinogenesis; 1996 Feb; 17(2):341-5. PubMed ID: 8625461
[TBL] [Abstract][Full Text] [Related]
56. RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancer.
Li J; Zhang Z; Dai Z; Popkie AP; Plass C; Morrison C; Wang Y; You M
Neoplasia; 2003; 5(4):362-6. PubMed ID: 14511407
[TBL] [Abstract][Full Text] [Related]
57. New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations.
Bleau AM; Freire J; Pajares MJ; Zudaire I; Anton I; Nistal-Villán E; Redrado M; Zandueta CN; Garmendia I; Ajona D; Blanco D; Pio R; Lecanda F; Calvo A; Montuenga LM
Int J Cancer; 2014 Dec; 135(11):2516-27. PubMed ID: 24473991
[TBL] [Abstract][Full Text] [Related]
58. Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level?
Bastide K; Ugolin N; Levalois C; Bernaudin JF; Chevillard S
Lung Cancer; 2010 Apr; 68(1):1-9. PubMed ID: 20004040
[TBL] [Abstract][Full Text] [Related]
59. The molecular genetics of human lung cancer.
Slebos RJ; Rodenhuis S
Eur Respir J; 1989 May; 2(5):461-9. PubMed ID: 2547647
[TBL] [Abstract][Full Text] [Related]
60. Protection against malignant conversion in SENCAR mouse skin by all trans retinoic acid: inhibition of the ras p21-processing enzyme farnesyltransferase and Ha-ras p21 membrane localization.
Agarwal R; Mohan RR; Ahmad N; Mukhtar H
Mol Carcinog; 1996 Sep; 17(1):13-22. PubMed ID: 8876671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
